3 Sales Growth Stocks to Buy Amid Renewed Middle East Tensions
An investment screening analysis identifies Globus Medical, NetApp, and Assurant as stocks worth buying based on strong sales growth and cash flow metrics. NetApp leads with expected fiscal 2027 sales growth of 18.6%, while Globus Medical targets 8.8% and Assurant expects 8.5% sales growth in 2026. All three stocks meet criteria including positive estimate revisions, strong operating margins, and favorable Zacks Rank ratings.